# Establishment and comparison of three sublines from a human uterine carcinosarcoma cell line, ESCA

**Authors:** Yixiu Long, Xuan Pei, Hongyu Liu, Xueyan Ouyang, Wei Jiang, Huijuan Yang

PMC · DOI: 10.1007/s13577-025-01225-8 · Human Cell · 2025-06-02

## TL;DR

Researchers developed and compared three sublines from a new human uterine carcinosarcoma cell line, ESCA, which could help study the disease's molecular mechanisms.

## Contribution

Establishment of a new cell line and its sublines with distinct drug sensitivities and growth characteristics for uterine carcinosarcoma research.

## Key findings

- ESCA sublines show varied morphology, growth, and drug sensitivity profiles.
- ESCA cells exhibit chromosomal abnormalities and similar mutations to the original tumor.
- ESCA-5 subline forms tumors with the fastest proliferation and low glucose uptake in mice.

## Abstract

The pathogenesis of uterine carcinosarcoma (UCS) remains unclear due to a few mature cell lines. Herein, we established a new cell line, ESCA, from a Chinese woman. Especially, three sublines, named ESCA-2, ESCA-3, ESCA-5, were isolated based on the rate of cells’ different sedimentation. All ESCA cells have been subcultured for more than 60 generations. ESCA sublines display different cell morphology and growth characteristics, as well as have different sensitivity to chemotherapeutic drugs. ESCA was most sensitive to paclitaxel and carboplatin, while ESCA-2 was most sensitive to ifosfamide. Besides, ESCA showed severe chromosome karyotype abnormalities and abnormal number of chromosomes. Whole exome sequence showed ESCA and its sublines, as well as tissue block shared similar single nucleotide variants, such as TP53, TRRAP mutations, while relatively large differences in mutational signature abundance. When all ESCA cells were xenotransplanted subcutaneously into BALB/c-nu mice, they developed into tumors that resembled the original tumor with positive AE1/3 and Vimentin in immunohistochemical staining. Interestingly, the transplanted tumor from ESCA-5 proliferated fastest with a relatively low level of glucose uptake evaluated by micro-PET/CT scanning. Taken together, ESCA and its sublines may be valuable tools to explore the molecular mechanism of UCS.

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157], TRRAP (transformation/transcription domain associated protein) [NCBI Gene 8295]
- **Chemicals:** paclitaxel (PubChem CID 36314), carboplatin (PubChem CID 426756), ifosfamide (PubChem CID 3690)
- **Diseases:** uterine carcinosarcoma (MONDO:0006485)

## Full-text entities

- **Genes:** TRRAP (transformation/transcription domain associated protein) [NCBI Gene 8295] {aka DEDDFA, DFNA75, PAF350/400, PAF400, STAF40, TR-AP}, VIM (vimentin) [NCBI Gene 7431], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** UCS (MESH:D002296), tumor (MESH:D009369)
- **Chemicals:** ifosfamide (MESH:D007069), glucose (MESH:D005947), paclitaxel (MESH:D017239), carboplatin (MESH:D016190)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** ESCA-5 — Mus musculus (Mouse), Transformed cell line (CVCL_5U93), ESCA-2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12130125/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12130125/full.md

---
Source: https://tomesphere.com/paper/PMC12130125